Sector portfolio · VC firm · United States

Mission BioCapital's Biotech portfolio

Mission BioCapital has backed 29 Biotech startups in rounds we track, $2.7B between them, shown by the stage each has reached. The best-funded is Dren Bio.

29startups backed
5stages
$2.7Braised between them
Series Bbiggest stage

Mission BioCapital's profile

Series B

8

Stage not reported

7

Series C and later

6

Pre-seed and seed

5

Series A

3

Segment by segment

Series B

8 startups · $1.1B raised

  1. Shape TherapeuticsA biotechnology company developing RNA technologies to shape the future of gene therapyUnited States$260M
  2. Tune TherapeuticsTune Therapeutics is a biotechnology company based in Durham, North Carolina, founded in 2020.United States$175M
  3. Nuvig TherapeuticsNuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune.United States$161M
  4. Mediar TherapeuticsMediar Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2018-2019.United States$161M
  5. Nocion TherapeuticsNocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.United States$112M
  6. EpiBiologicsEpiBiologics is a biotechnology company based in San Mateo, California, founded in 2022.United States$107M
  7. QurAlisQurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.United States$94M
  8. Arkuda TherapeuticsArkuda Therapeutics is a biotechnology company based in Watertown, MA, dedicated to developing medicines for neurodegenerative diseases.United States$64M

Stage not reported

7 startups · $734M raised

  1. Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
  2. Pionyr ImmunotherapeuticsPionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.-$275M
  3. Jupiter BioVenturesJupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects.United States$70M
  4. MMitokininMitokinin is operates in the healthcare industry focusing on biotechnology business.United States$5.0M
  5. AmbAgon TherapeuticsAmbagon Therapeutics is a biotechnology company focused on developing innovative therapies for challenging protein targets, particUnited States$5.0M
  6. ATAvexegen TherapeuticsAvexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.-$2.9M
  7. Tangible ScienceTangible Science is a specialty contact lens care company based in Redwood City, California.United States$1.4M

Series C and later

6 startups · $681M raised

  1. Circle PharmaCircle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.United States$187M
  2. GlycomineGlycomine is an early-stage biotech working on replacement therapies for rare diseases.United States$160M
  3. STSiteOne TherapeuticsUnited States$119M
  4. Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
  5. Vivace TherapeuticsVivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.United States$75M
  6. Symic BioSymic Bio is a biopharmaceutical company based in San Francisco, California, founded in 2012.United States$41M

Pre-seed and seed

5 startups · $67M raised

  1. Cloverleaf BioCloverleaf Bio is a biotechnology company based in New Haven, Connecticut, founded in 2023.United States$33M
  2. Enodia TherapeuticsEnodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.France$24M
  3. TippingPoint BiosciencesTippingPoint Biosciences is a biotechnology company based in San Francisco, California, dedicated to developing innovative therapiUnited States$4.5M
  4. Deck BioDeck Bio develops multi-target T cell engager immunotherapies for solid tumors.United States$3.1M
  5. BBBeech BiotechBeech Biotech is utilizing cutting-edge biology to develop innovative therapies for preeclampsia and other pregnancy-related issues.Switzerland$2.4M

Series A

3 startups · $122M raised

  1. PTProgentos TherapeuticsProgentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.United States$65M
  2. March BiosciencesMarch Biosciences is a clinical-stage cell therapy company based in Houston, Texas.United States$29M
  3. CTComet TherapeuticsComet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.United States$29M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Mission BioCapital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Mission BioCapital26 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179BSector portfolioSequoia Capital's AI portfolio209 startups · $543B

Raising from investors like Mission BioCapital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps